State AZ
Clinical Trials in Arizona
Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 268 actively recruiting studies with Arizona sites out of 268 registered in total. The busiest research areas in Arizona are Heart Failure, Breast Cancer, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include AstraZeneca, University of Arizona, Eli Lilly and Company. By stage, Arizona trials break down as Phase 1 (42), Phase 2 (77), Phase 3 (93), Phase 4 (11).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Arizona
Frequently Asked Questions — Clinical Trials in Arizona
How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 268 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 268. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Heart Failure, Breast Cancer, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Arizona
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT07248839 Phase 1
Recruiting
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With ...
Condition
Healthy Volunteers
Enrollment
24 pts
Location
United States
Sponsor
Bristol-Myers Squibb
NCT06427941 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With o...
Condition
Metastatic Hepatocellular Carcinoma
Enrollment
630 pts
Location
United States, Brazil, China
Sponsor
BeOne Medicines
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
1,160 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06213090 N/A
Recruiting
Patterns of Neurodevelopmental Disorders
Condition
Neurodevelopmental Disorders
Enrollment
1,000 pts
Location
United States
Sponsor
Richard Frye
NCT07216027 Phase 2
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Condition
Atopic Dermatitis
Enrollment
165 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT05836090 N/A
Recruiting
Family Spirit Strengths
Condition
Depressive Symptoms
Enrollment
188 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT07362017 Phase 3
Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate...
Condition
Moderate-to-severe Chronic Plaque Psoriasis
Enrollment
300 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
NCT05317858 Phase 3
Recruiting
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standar...
Condition
Brain Tumor
Enrollment
30 pts
Location
United States, Canada, South Korea
Sponsor
InSightec
NCT06842498 Phase 2
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate...
Condition
Metastatic Castration-Resistant Prostate Cancer
Enrollment
75 pts
Location
United States
Sponsor
Kyntra Bio
NCT07196748 Phase 3
Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Mode...
Condition
Colitis, Ulcerative
Enrollment
882 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, China, France
Sponsor
Stoke Therapeutics, Inc
NCT05899608 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
1,600 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
NCT07652658 Phase 2
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
359 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07219953 Phase 3
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
NCT06388967 N/A
Recruiting
Pancreatic Cancer Detection Consortium
Condition
Pancreatic Cancer
Enrollment
2,000 pts
Location
United States, Japan, South Korea
Sponsor
City of Hope Medical Center
NCT06333171 Phase 2
Recruiting
4-aminopyridine for Skin Wound Healing
Condition
Wounds
Enrollment
150 pts
Location
United States
Sponsor
John Elfar
NCT04339699 N/A
Recruiting
NobleStitch EL STITCH Trial is a PFO Comparative Trial
Condition
Foramen Ovale, Patent
Enrollment
640 pts
Location
United States, Italy
Sponsor
Nobles Medical Technologies II
NCT05034432 Phase 4
Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventri...
Condition
Arrythmia
Enrollment
100 pts
Location
United States
Sponsor
University of Rochester
NCT06491732 N/A
Recruiting
EIM Via the Myolex mScan as an ALS Biomarker
Condition
Amyotrophic Lateral Sclerosis
Enrollment
80 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
NCT05877599 Phase 1
Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Posi...
Condition
Non-small Cell Lung Cancer
Enrollment
45 pts
Location
United States
Sponsor
AstraZeneca
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology